AAPL 189.07 +0.3 (+0.16%)MSFT 117.02 -0.72 (-0.62%)FB 167.35 +1.05 (+0.63%)ZNGA 5.3 -0.01 (-0.19%)NVDA 175.17 +1.31 (+0.75%)WBA 61.7 +0.14 (+0.23%)GOOG 1184.77 -8.35 (-0.70%)PIH 5.45 -0.16 (-2.85%)
AAPL 189.07 +0.3 (+0.16%)MSFT 117.02 -0.72 (-0.62%)FB 167.35 +1.05 (+0.63%)ZNGA 5.3 -0.01 (-0.19%)NVDA 175.17 +1.31 (+0.75%)WBA 61.7 +0.14 (+0.23%)GOOG 1184.77 -8.35 (-0.70%)PIH 5.45 -0.16 (-2.85%)

Financial Summary DOVA Quote Dova Pharma

Dova Pharmaceuticals Inc. Quote

Dova Pharmaceut (DOVA)

8.69 0.13 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol DOVA
Price 8.69
Beta 1.01
Vol Avg 176.23 K
Mkt cap 753.17 M
Shares 28
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -189.47% Strong Sell
ROA -128.57% Strong Sell
Operating Margin -710.00% Strong Sell
Debt/Equity 47.37% Neutral
P/E -3.38 Strong Sell
P/B 3.20 Strong Buy
Company Profile

CEO

Alex Sapir

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Global Market

Description

Dova Pharmaceuticals Inc is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia.